Skip to content
★ Sign in to follow
LS
Total declarations
50
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (16 ops.)
€10.6M

Latest filing published 20 Jun 2019 for BIOGEN INC..

Filing timeline

BuySale
Lynn Schenk

Insider track record

Disclosed buys
0
Disclosed sells
16
Signal history

Lynn Schenk: trading record in brief

Lynn Schenk discloses dealings in 2 companies, chiefly Biogen Inc. and Sempra. In total, 50 filings cover trades dated from 25 January 2005 to 19 June 2019.

Every open-market trade on record is a sale: 16 sales worth €10.6M. Besides market trades, the filings include 16 share grants and 17 option exercises. In 2019 alone, the filings show no purchases and 2 sales.

Most recently, on 20 June 2019, the filings show a share grant in Biogen Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Lynn Schenk

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations50 total
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    1,155 shares0Common StockSEC:0001127602-19-022429:0
  • ◇
    DirectorExecutivesSempra
    230,100 USD13SEC
    5,000 shares@ US$46.0216.4% of flowCommon StockSEC:0001228379-19-000052:0
  • ▼
    DirectorExecutivesSempra
    644,600 USD16SEC
    5,000 shares@ US$128.9246.0% of flowCommon StockSEC:0001228379-19-000052:1
  • ▼
    DirectorExecutivesSempra
    535,450 USD15SEC
    5,000 shares@ US$107.0937.6% of flowCommon StockSEC:0001228379-19-000010:0
  • ●
    DirectorExecutivesBiogen Inc.
    0SEC
    32 shares0Common StockSEC:0001127602-18-035013:0
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    880 shares0Common StockSEC:0001127602-18-020940:0
  • ◇
    DirectorExecutivesSempra
    640,875 USD14SEC
    12,500 shares@ US$51.2730.3% of flowCommon StockSEC:0001228379-17-000104:0
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    1,055 shares0Common StockSEC:0001127602-17-021095:0
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    1,060 shares0Common StockSEC:0001127602-16-055212:0
  • ◆
    DirectorExecutivesSempra
    0SEC
    570 sharesCommon StockSEC:0001228379-16-000128:0
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    695 shares0Common StockSEC:0001127602-15-020460:0
  • ◆
    DirectorExecutivesSempra
    0SEC
    576 sharesCommon StockSEC:0001228379-15-000045:0
  • ◇
    DirectorExecutivesSempra
    128,175 USD0SEC
    2,500 shares@ US$51.27Common StockSEC:0001228379-14-000065:0
  • ▼
    DirectorExecutivesSempra
    262,500 USD0SEC
    2,500 shares@ US$105.00Common StockSEC:0001228379-14-000065:1
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    870 shares0Common StockSEC:0001127602-14-020935:0
  • ◆
    DirectorExecutivesSempra
    0SEC
    611 sharesCommon StockSEC:0001228379-14-000055:0
  • ▼
    DirectorExecutivesBiogen Inc.
    297,480 USD0SEC
    1,000 shares@ US$297.48Common StockSEC:0001127602-14-002007:0
  • ▼
    DirectorExecutivesBiogen Inc.
    291,710 USD0SEC
    1,000 shares@ US$291.71Common StockSEC:0001127602-13-033273:0
  • ▼
    DirectorExecutivesBiogen Inc.
    245,000 USD0SEC
    1,000 shares@ US$245.00Common StockSEC:0001127602-13-030554:0
  • ▼
    DirectorExecutivesBiogen Inc.
    242,850 USD0SEC
    1,000 shares@ US$242.85Common StockSEC:0001127602-13-028575:0
  • ▼
    DirectorExecutivesBiogen Inc.
    211,725 USD0SEC
    900 shares@ US$235.25Common StockSEC:0001127602-13-027119:0
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    1,305 shares0Common StockSEC:0001127602-13-020325:0
  • ▼
    DirectorExecutivesBiogen Inc.
    225,960 USD0SEC
    1,000 shares@ US$225.96Common StockSEC:0001127602-13-020031:0
  • ▼
    DirectorExecutivesBiogen Inc.
    225,670 USD0SEC
    1,000 shares@ US$225.67Common StockSEC:0001127602-13-020031:1
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    2,020 shares0Common StockSEC:0001127602-12-019799:0

25 of 50 declarations